Flexible U.S. Biomanufacturing Capacity

We provide pre-clinical and clinical scale biologics contract manufacturing services in the heart of San Antonio, Texas. The facility includes 8,600 total square feet of cGMP-compliant cleanroom biomanufacturing space, a 2,000 square-foot process development lab, and a 2,000 square-foot analytical testing lab, as well as office, meeting, warehouse, and mechanical space. Controlled, classified cleanroom space is segregated into two independent biologic manufacturing areas, located in two separate buildings on the VelocityTX campus.

We're proud to give innovative small-scale, early-stage programs the attention and flexibility other CDMOs don't. Scorpius provides cGMP contract manufacturing for therapeutic proteins, vaccines, and vectors produced in both mammalian and microbial systems. Scorpius' biomanufacturing facilities provide world-class capabilities utilizing single-use, disposable technology. Single-use systems reduce the risk of contamination and/or cross-contamination, allow for quick changeover between batches, and reduce or eliminate the need for cleaning validation studies.

Our Manufacturing Capabilities:

Mammalian Cell Culture	Microbial Fermentation	Antibody Production	Vaccine Manufacturing

Available U.S. Biologics Capacity

Scorpius utilizes American-manufactured equipment and consumables, such as the Pall Allegro^™ STR single-use family of stirred tank bioreactors that deliver consistent and scalable cell culture and microbial fermentation performance. Current capabilities include 50, 200, and 500 L mammalian cell culture bioreactors and 50 and 200 L microbial fermentation reactors. Cell harvest capabilities include bioprocess-scale centrifugation, continuous flow centrifugation, kSep 400 as well as microfiltration. Downstream process capabilities include ultrafiltration/diafiltration, column chromatography, and sterile filtration.